# A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

> **NCT00536471** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 776 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00536471
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-05
- **Final completion:** 2008-12
- **Target enrollment:** 776 (ACTUAL)
- **Last updated:** 2009-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536471, "A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00536471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*